Maintenance. We are currently updating the site. Please check back shortly
Members login
  • TrustLaw
  • Members Portal

Merck agrees to settle litigation over Fosamax jaw injuries

Source: Reuters - Mon, 9 Dec 2013 07:46 PM
Author: Reuters
Tweet Recommend Google + LinkedIn Bookmark Email Print
Leave us a comment

NEW YORK, Dec 9 (Reuters) - Merck & Co has agreed to settle hundreds of lawsuits over jaw injuries allegedly caused by the osteoporosis drug Fosamax, lawyers disclosed at a court hearing Monday.

Lawyers for Merck and plaintiffs pursuing litigation over the once-blockbuster drug revealed at a court hearing in New York that a proposed deal had been reached to resolve 1,140 lawsuits pending in federal and state courts.

Terms were not disclosed at the hearing before U.S. District Judge John Keenan, who has presided over federal litigation by plaintiffs claiming they developed osteonecrosis of the jaw from Fosamax.

Tim O'Brien, a lawyer at Levin, Papantonio, Thomas, Mitchell, Rafferty & Proctor who represents Fosamax plaintiffs, confirmed in an email that the parties had agreed to a "global settlement process."

A spokeswoman for Merck did not immediately respond to a request for comment.

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of the Thomson Reuters Foundation. For more information see our Acceptable Use Policy.

comments powered by Disqus
Topical content

Latest slideshow

See allSee all
Featured jobs